Archive for the ‘High blood-pressure’ tag
Intuniv – launch 3-page print ad
Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD
Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD
To see all of the ads from this campaign, click here
Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009
To see all of this brand’s ads on AdPharm, click here
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Olmetec and Olmetec Plus
Prenez le contrôle pour aider à la maîtrise de la T.A.
Olmetec – une puissance pour aider au contrôle de la T.A.
[Road sign] Maintenant sur la liste de médicaments du Québec.
Take charge to help control BP
Olmetec has power to help control BP.
[Road sign] Now on the Quebec list of medications
Brand name: Olmetec
Generic name/category: Olmesartan, Angiotensin II receptor antagonists (ARA – ARB), Imidazoles
Company: Schering-Plough
Country/Market: Canada, North America
Indication(s)/use: Hypertension, High Blood Pressure (HBP)
Target: Healthcare Professionals (HCP)
Tagline:
Prenez le contrôle pour aider à la maîtrise de la T.A.
Take charge to help control BP
Medium: Print ad
Size/duration: single-page
Publication/Aired: Le Patient – vol.3 no.3 – August 2009
To see all of this brand’s ads on AdPharm, click here
Toprol-XL
Come back to Toprol-XL and its generic equivalent (metoprol succinate) for once-daily blood pressure medicine.
“Convenient”. “Once daily”. “It’s available as a generic – ask your doctor”.
Brand name: Toprol-XL
Generic name/category: Metoprolol, Beta blockers
Company: AstraZeneca PAR Pharmaceutical
Country/Market: USA, North America
Indication(s)/use: High Blood Pressure (HBP)
Target: Consumers (DTC)
Publication: People Magazine June 15 2009
To see all of this brand’s ads on AdPharm, click here
Adalat XL
Consider every link
Forge your link in hypertension and chronic stable angina with Adalat XL
3 dose strengths: 20, 30 and 60 mg
Brand name: Adalat XL
Generic name/category: Nifedipine, dihydropyridine calcium channel blocker
Company: Bayer healthcare
Country/Market: Canada, North America
Indication(s)/use: antianginal (especially in Prinzmetal’s angina) and antihypertensive (HBP)
Target: Consumers (DTC) / Healthcare Professionals (HCP) / Trade
Tagline: Because it works
Publication: Canadian Journal of General Internal Medicine May 2009
To see all of this brand’s ads on AdPharm, click here
Caduet DTC print ad
“How close are you to your blood pressure and cholesterol goals?”
Ask your doctor if caduet can help you go for both your goals
and visit www.caduet.com to learn more.
Caduet is a medication approved by the US FDA for the treatment of high cholesterol and high blood pressure. It is a fixed dose combination drug containing amlodipine, a calcium channel blocker (commonly sold as Norvasc), and atorvastatin (Lipitor). In many other countries, the combination is sold as Envacar. It is currently being marketed by the pharmaceutical company Pfizer.
Brand name: Caduet
Generic name/category: atorvastatin and amlodipine
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: dyslipidemia, High cholesterol and hypertension
Target: Consumers (DTC)
Publication: Reader’s Digest June 2009
Coricidin HBP
Powerful cold medicine with a heart
Some cold medicines can raise your high blood pressure even higher. Coricidin HBP won’t.
Coricidin, Coricidin ‘D’ (decongestant), or CoricidinHBP (for high blood pressure), is the name of a drug marketed by Schering-Plough that contains dextromethorphan (a cough suppressant) and chlorpheniramine maleate (an antihistamine). Varieties of Coricidin may also contain acetaminophen (an analgesic/antipyretic) and guaifenesin (an expectorant). – Wikipedia
Reader’s Digest march 2009
Olmetec and Olmetec Plus
| Take charge to help control BP Olmetec has power to help control BP. Olmesartan (trade names Benicar, Olmetec) is an angiotensin II receptor antagonist used to treat high blood pressure. The prodrug olmesartan medoxomil is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. and Forest Laboratories. Olmesartan works by blocking the binding of angiotensin II to the AT1 receptors in vascular muscle; it is therefore independent of angiotensin II synthesis pathways, unlike ACE inhibitors. By blocking binding rather than synthesis of angiotensin II, olmesartan inhibits the negative regulatory feedback on renin secretion. As a result of this blockage, olmesartan reduces vasoconstriction and the secretion of aldosterone. This lowers blood pressure by producing vasodilation, and decreasing peripheral resistance. Olmesartan may possess high affinity for the Vitamin D Receptor, based on molecular modeling studies, but these results have not been duplicated in clinical trials. Because of the role of the Vitamin D receptor in innate immunity, this would indicate that olmesartan has immune modulatory properties. This theory is currently the premise underlying the Marshall Protocol, which uses olmesartan to impose a chemical blockade on 1,25 Vitamin D as part of a treatment of sarcoidosis and other diseases. The Marshall Protocol asserts that, assuming the etiology of these diseases is based on infection by cell-wall-deficient bacteria, restoring proper Vitamin D ratios via olmesartan dosing, combined with pulsed antibiotic dosing, would result in a cure. – Wikipedia Parkhurst Exchange April 2009 |
